Literature DB >> 8226163

Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy.

P A Johnstone1, L J Pierce, M J Merino, J C Yang, A H Epstein, T F DeLaney.   

Abstract

PURPOSE: A retrospective analysis was undertaken to determine the efficacy of postoperative radiotherapy in patients with primary sarcoma of the breast. METHODS AND MATERIALS: Ten patients with high-grade nonmetastatic primary sarcoma of the breast were treated at the National Cancer Institute, NIH, between 1979 and 1989 with mastectomy and adjuvant radiotherapy. Chemotherapy was given to three patients as part of a randomized trial.
RESULTS: With a median potential followup of 99 months postoperatively, seven patients remain alive and without evidence of disease 142, 119, 82, 48, 45, 28, and 19 months postoperatively. Three patients died of metastatic disease 7, 25, and 29 months, postoperatively. There were no local or regional failures. Actuarial 5-year disease free and overall survival were 68% and 66%, respectively.
CONCLUSION: Sarcomas of the breast have a prognosis similar to that of extremity sarcomas. When adjuvant radiotherapy is used, excellent local control may be achieved.

Entities:  

Mesh:

Year:  1993        PMID: 8226163     DOI: 10.1016/0360-3016(93)90395-c

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Primary and secondary angiosarcoma of the breast.

Authors:  Tania K Arora; Krista P Terracina; John Soong; Michael O Idowu; Kazuaki Takabe
Journal:  Gland Surg       Date:  2014-02

2.  Liposarcoma of the breast arising in a malignant phyllodes tumor: A case report and review of the literature.

Authors:  Malgorzata Banys-Paluchowski; Eike Burandt; Alexander Quaas; Waldemar Wilczak; Stefan Geist; Guido Sauter; Natalia Krawczyk; Klaus Pietzner; Peter Paluchowski
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 3.  Breast angiosarcoma that is not related to radiation exposure: a comprehensive review of the literature.

Authors:  Ioannis G Kaklamanos; Konstantinos Birbas; Konstantinos N Syrigos; Dimitrios Vlachodimitropoulos; Nikolaos Goutas; Gerassimos Bonatsos
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

4.  Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience.

Authors:  M Kunkiel; M Maczkiewicz; A Jagiełło-Gruszfeld; Z Nowecki
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

5.  Primary Spindle Cell Sarcoma of the Breast.

Authors:  Timucin Cil; Abdullah Altintas; Semir Pasa; Huseyin Buyukbayram; Abdurrahman Isikdogan
Journal:  Breast Care (Basel)       Date:  2008-06-04       Impact factor: 2.860

6.  Primary epithelioid angiosarcoma of the male breast: report of a case.

Authors:  Ze-Sheng Wang; Na Zhan; Cheng-Long Xiong; Hui Li
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

7.  The Role of Adjuvant Radiotherapy for a Case of Primary Breast Sarcoma: A Plan Comparison between Three Modern Techniques and a Review of the Literature.

Authors:  Mariella Cozzolino; Caterina Oliviero; Barbara D'Andrea; Giuseppe Guglielmi; Giorgia Califano; Rocchina Caivano; Antonella Bianculli; Vincenzo Fusco
Journal:  Case Rep Med       Date:  2018-04-17

8.  Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report.

Authors:  Rita De Sanctis; Elena Lorenzi; Elisa Agostinetto; Tania D'Amico; Matteo Simonelli; Armando Santoro
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 9.  Primary soft tissue sarcoma of the breast.

Authors:  J C Trent II; R S Benjamin; V Valero
Journal:  Curr Treat Options Oncol       Date:  2001-04

Review 10.  Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature.

Authors:  C Adem; C Reynolds; J N Ingle; A G Nascimento
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.